pefloxacine
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- Topoisomerase IVINHIBITOR
Topoisomerase IV inhibitor
- Bacterial DNA gyraseINHIBITOR
Bacterial DNA gyrase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21- Mol. weight
- 333.36 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL267648 ↗
Also known as
- 1589 rb
- 1589 rb
- eu-5306
- eu-5306
- labocton
- labocton
- peflacine
- pefloxacin
- pefloxacin
- pefloxacin
- pefloxacin
- pefloxacin
- pefloxacin
- pefloxacin
- pefloxacine
- pefloxacine
- pefloxacine
- pefloxacino
- pefloxacino
- pefloxacinum
- pefloxacinum
- pflx
- pflx